1. Expert Opinion on Verification of Antimicrobial Susceptibility Tests
- Author
-
Shawn R. Lockhart, Richard B. Thomson, Ribhi M. Shawar, Esther Babady, Sandra S. Richter, Ana María Cárdenas, Margie Morgan, Marcelo Galas, Kevin Alby, Mark G. Papich, Nicole Hubbard, Audrey N. Schuetz, Karissa Culbreath, German Esparza, Brian V. Lubbers, Jean B. Patel, and Susan E. Sharp
- Subjects
Microbiology (medical) ,ANTIMICROBIAL SUSCEPTIBILITY TESTS ,medicine.medical_specialty ,medicine.drug_class ,business.industry ,Antibiotics ,Antimicrobial susceptibility ,Microbial Sensitivity Tests ,Antimicrobial ,Anti-Bacterial Agents ,Anti-Infective Agents ,Expert opinion ,polycyclic compounds ,medicine ,Humans ,Pseudomonas Infections ,business ,Intensive care medicine ,Expert Testimony ,Letter to the Editor - Abstract
On behalf of the Clinical and Laboratory Standards Institute (CLSI), the Expert Panel on Microbiology would like to respond to the recent commentary by Kirby and colleagues voicing concerns related to verification of commercial antimicrobial susceptibility testing (AST) for new drugs that are introduced into the clinical laboratory (1).…
- Published
- 2020
- Full Text
- View/download PDF